Navigation Links
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Date:8/22/2007

ders including acute ischemic stroke and catheter occlusion and preclinical candidates NU206 for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease and NU172, a direct thrombin inhibitor for use as a short-acting anticoagulant during medical or surgical procedures. In addition, Nuvelo expects to leverage its expertise in cancer antibody discovery to further expand its pipeline and create additional partnering and licensing opportunities.

Information about Nuvelo is available at our website at http://www.nuvelo.com or by phoning 650-517-8000.

This press release contains "forward-looking statements" regarding the timing and progress of Nuvelo's clinical programs, including the timing of the availability of data from Nuvelo's Phase 3 alfimeprase trials, the potential improvement or benefit that current and future clinical trial programs may demonstrate, and our anticipated revenues, operating expenses and net cash used in operations, which statements are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements are based on our management's current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, uncertainties relating to drug discovery; clinical development processes; enrollment rates for patients in our clinical trials; changes in relationships with strategic partners and dependence upon strategic partners for the performance of critical activities under collaborative agreements; the impact of competitive products and technological changes; and uncertainties relating to our ability to obtain funding. These and other factors are identified and described in more detail in Nuvelo fi
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
3. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
4. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
5. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
6. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 24, 2014  As the building blocks of ... access to diverse skill sets and expertise, knowledge ... business hours for efficiency. However, effectively managing these ... According to recent research, more than 25 ... a project not move forward due to lack ...
(Date:10/22/2014)... N.J. , Oct. 22, 2014  Rescheduling ... major transformation in the pain market, according to ... Insights, Inc., a firm providing market research and ... Photo - http://photos.prnewswire.com/prnh/20141021/153440 ... scheduling change for hydrocodone combination products from Schedule ...
(Date:10/22/2014)... 2014 Antigen Discovery Inc. (ADi), a privately ... announced the receipt of a National Institutes of Health ... National Institute of Dental and Craniofacial Research (NIDCR). The ... Pan-HIV Protein Microarray Chip, which will contain every protein ... aid in the development of safe and effective vaccines ...
Breaking Medicine Technology:Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
... this week,s 46th Annual Midyear Clinical Meeting and Exhibition ... Health launched BarCode360™ , a solution that supports ... timely and cost efficient to order medications and ensure ... bedside. ASHP has set a goal for ...
... The Ministry of Health and Welfare and The Korean ... Dhabi and four Korean hospitals, including Samsung Seoul Hospital, ... St. Mary,s Hospital have signed an agreement to collaborate ... Nov. 25. This agreement represents the first ...
Cached Medicine Technology:Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 2Cardinal Health Launches Innovative Barcode Administration Solution to Help Hospitals Bridge Gaps in Medication Safety 3South Korea Signs Accord with Abu Dhabi Health Authority on Hospital Service Agreement 2
(Date:10/25/2014)... (PRWEB) October 26, 2014 BioSkinLaser.Com, the ... the most advanced and improved laser treatments for its ... safe treatments like the lip enhancement treatment . ... with specific focus areas of each customer. , BioSkinLaser.Com ... cellulite reduction NYC . The company cited that it ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage ... a pioneer in the field of establishing recovery community organizations. ... system and when he retired, he set out to answer ... service. , 1. Where are the people ... , 2. Can the recovery community be organized to ...
(Date:10/25/2014)... Homeowners that are wondering how they can ... no more. Clean Crawls gives 5 signs of ... when it comes to insulation in their recently released ... by Clean Crawls, can cause problems throughout your entire ... has deteriorated, become damp, or been infested with pests ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... Randy Dotinga HealthDay ... As more genetic tests are developed that spot increased risks ... be more proactive about getting screened. But a new ... not change behavior: People who found out their genes doubled ... people with average risk to get screened. "It didn,t ...
Breaking Medicine News(10 mins):Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2
... News) -- The holiday season can be a challenge for ... of things they can do to protect themselves, allergists say. ... foods contain such allergens as wheat, soy, dairy and nuts, ... American College of Allergy, Asthma and Immunology (ACAAI). For ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... Americans are hospitalized for adverse drug reactions yearly, and ... a new study finds. The four types of ... -- account for two-thirds of those drug-related emergency hospitalizations. ...
... , Increased consumption of ground beef or processed meat ... study published Nov. 23 in the online journal ... John Witte of University of California, San Francisco, also found ... was grilled or barbequed, especially when well done. ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Nov. 23 ... in the 1970s and 1980s and appear to be on the ... a new study finds. "It,s not just kids who ... entire shift. Even those who are normal weight are gaining weight," ...
... Serena Gordon HealthDay Reporter , WEDNESDAY, Nov. ... episodes but not an asthma diagnosis are often prescribed ... to take those medications on an as-needed basis instead ... trigger severe wheezing in young children, and the treatment ...
... Strasbourg --,The European Science Foundation (ESF) has awarded this ... of the Max Planck Institute for Demographic Research in ... "Demography." Professor Vaupel was awarded the prize for his ... profound influence on demographic research. The Prize was awarded ...
Cached Medicine News:Health News:Allergy Sufferers Should Prepare for Holiday Triggers 2Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 2Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 3Health News:Many Kindergarteners Already on Road to Obesity, Study Finds 2Health News:Many Kindergarteners Already on Road to Obesity, Study Finds 3Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 3Health News:ESF awards 13th European Latsis Prize to James Vaupel on pioneering demographic research 2
... versatile, dependable 990 frame the ... and completes the Nova diagnostic ... stands out due to its ... and its integral safety cut ...
... Superior optics and workmanship are the ... with temperature sensitivity in mind. The top ... unequalled illumination, eliminating shadows while remaining cool ... models are available with 10x to 44x ...
... wave imaging system utilizes an evanescent ... the thin section in contact with ... unique design permits simultaneous mounting of ... with no restriction on their individual ...
... video camera with direct digital output. Three-chip ... applications. Olympus wide array of high-quality color ... quality and flexibility you need for an ... a high-resolution, real-time image of your specimen ...
Medicine Products: